393 related articles for article (PubMed ID: 32440558)
41. Secretory function of adipose tissue.
Kuryszko J; Sławuta P; Sapikowski G
Pol J Vet Sci; 2016; 19(2):441-6. PubMed ID: 27487522
[TBL] [Abstract][Full Text] [Related]
42. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro.
Lappas M; Yee K; Permezel M; Rice GE
Endocrinology; 2005 Mar; 146(3):1491-7. PubMed ID: 15564333
[TBL] [Abstract][Full Text] [Related]
43. [Adipocytokines: implications in the prognosis and drug treatment of cardiovascular diseases].
Iglesias-Osma MC; Torres MA; García-Barrado MJ; Moratinos J
Rev Clin Esp; 2008 May; 208(5):239-46. PubMed ID: 18457636
[TBL] [Abstract][Full Text] [Related]
44. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus.
Catalán V; Gómez-Ambrosi J; Rotellar F; Silva C; Gil MJ; Rodríguez A; Cienfuegos JA; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2007 Apr; 66(4):598-601. PubMed ID: 17371481
[TBL] [Abstract][Full Text] [Related]
45. β-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKKβ/NF-κB and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.
Jayaraman S; Devarajan N; Rajagopal P; Babu S; Ganesan SK; Veeraraghavan VP; Palanisamy CP; Cui B; Periyasamy V; Chandrasekar K
Molecules; 2021 Apr; 26(7):. PubMed ID: 33917607
[TBL] [Abstract][Full Text] [Related]
46. [Acute-phase serum proteins and adipocytokines in women with type 2 diabetes mellitus: Relationships with body composition and blood glucose fluctuations].
Klimontov VV; Tyan NV; Fazullina ON; Myakina NE; Orlov NB; Konenkov VI
Ter Arkh; 2016; 88(10):35-41. PubMed ID: 27801417
[TBL] [Abstract][Full Text] [Related]
47. Plasma concentration and expression of adipokines in epicardial and subcutaneous adipose tissue are associated with impaired left ventricular filling pattern.
Toczylowski K; Hirnle T; Harasiuk D; Zabielski P; Lewczuk A; Dmitruk I; Ksiazek M; Sulik A; Gorski J; Chabowski A; Baranowski M
J Transl Med; 2019 Sep; 17(1):310. PubMed ID: 31533725
[TBL] [Abstract][Full Text] [Related]
48. Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach.
Batiha GE; Al-Kuraishy HM; Al-Gareeb AI; Ashour NA; Negm WA
Inflammopharmacology; 2023 Aug; 31(4):1683-1693. PubMed ID: 37208555
[TBL] [Abstract][Full Text] [Related]
49. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Silva C; Rotellar F; Gil MJ; Cienfuegos JA; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Feb; 68(2):213-9. PubMed ID: 17803693
[TBL] [Abstract][Full Text] [Related]
50. Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes.
Garvey WT; Van Gaal L; Leiter LA; Vijapurkar U; List J; Cuddihy R; Ren J; Davies MJ
Metabolism; 2018 Aug; 85():32-37. PubMed ID: 29452178
[TBL] [Abstract][Full Text] [Related]
51. Adipocytokines and the metabolic complications of obesity.
Rasouli N; Kern PA
J Clin Endocrinol Metab; 2008 Nov; 93(11 Suppl 1):S64-73. PubMed ID: 18987272
[TBL] [Abstract][Full Text] [Related]
52. Adipokines mediate inflammation and insulin resistance.
Kwon H; Pessin JE
Front Endocrinol (Lausanne); 2013; 4():71. PubMed ID: 23781214
[TBL] [Abstract][Full Text] [Related]
53. Adipose tissue inflammation and ectopic lipid accumulation.
Suganami T; Tanaka M; Ogawa Y
Endocr J; 2012; 59(10):849-57. PubMed ID: 22878669
[TBL] [Abstract][Full Text] [Related]
54. Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance.
Al-Mansoori L; Al-Jaber H; Prince MS; Elrayess MA
Inflammation; 2022 Feb; 45(1):31-44. PubMed ID: 34536157
[TBL] [Abstract][Full Text] [Related]
55. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.
Schäffler A; Schölmerich J; Büchler C
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231
[TBL] [Abstract][Full Text] [Related]
56. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.
Fain JN
Vitam Horm; 2006; 74():443-77. PubMed ID: 17027526
[TBL] [Abstract][Full Text] [Related]
57. Obesity and diabetes: the link between adipose tissue dysfunction and glucose homeostasis.
Abranches MV; Oliveira FC; Conceição LL; Peluzio MD
Nutr Res Rev; 2015 Dec; 28(2):121-132. PubMed ID: 26650242
[TBL] [Abstract][Full Text] [Related]
58. Adipokines and insulin action: A sensitive issue.
Knights AJ; Funnell AP; Pearson RC; Crossley M; Bell-Anderson KS
Adipocyte; 2014 Apr; 3(2):88-96. PubMed ID: 24719781
[TBL] [Abstract][Full Text] [Related]
59. Metformin versus insulin for gestational diabetes: Adiposity variables and adipocytokines in offspring at age of 9 years.
Paavilainen E; Niinikoski H; Parkkola R; Koskensalo K; Nikkinen H; Veijola R; Vääräsmäki M; Loo BM; Tossavainen P; Rönnemaa T; Tertti K
Diabetes Res Clin Pract; 2023 Aug; 202():110780. PubMed ID: 37331522
[TBL] [Abstract][Full Text] [Related]
60. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?
Sell H; Eckel J
Proc Nutr Soc; 2009 Nov; 68(4):378-84. PubMed ID: 19698204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]